Business ❯Pharmaceutical Industry

Drug Development

Apple Healthcare Access Food and Drug Administration Diabetes Patient Outcomes Vertex Pharmaceuticals Investigative Reporting Weight Loss Drugs Neurology Financial News

FDA Approves Yeztugo, a Twice-Yearly Shot to Prevent HIV

Advocates caution that proposed federal funding reductions coupled with steep pricing could limit distribution of the twice-yearly injection

FDA Launches National Priority Voucher Program to Slash Drug Review Times

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Parkinson’s and RLS Drug Linked to Risky Impulse Behaviors

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock